VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

BeOne Medicines Ltd. (ONC) Total Return Calculator with Dividends Reinvested

BeOne Medicines Ltd.

Popular:

The total return for BeOne Medicines Ltd. (ONC) stock is +29.60% over the past 12 months. So far it's up 0.74% this year. The 5-year total return is -0.22%, meaning $10,000 invested in ONC stock 5 years ago would be worth $9,978 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in ONC 1 year ago, it would be worth $13,491 today — you'd have gained $3,491.

With Dividends Reinvested$13,491+34.91%

Price Only (No DRIP)$13,491+34.91%

Period2025-05-07 → 2026-05-06

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in ONC

1Y$12,961+$2,961 (+29.6%)29.6% CAGR

3Y$12,339+$2,339 (+23.4%)7.3% CAGR

5Y$9,978-$22 (-0.2%)-0.0% CAGR

10Y$119,405+$109,405 (+1094.1%)28.1% CAGR

15Y$110,636+$100,636 (+1006.4%)17.4% CAGR

20Y$110,636+$100,636 (+1006.4%)12.8% CAGR

30Y$110,635+$100,635 (+1006.4%)8.3% CAGR

BeOne Medicines Ltd. did not pay dividends during this period. Total return = price return.

Loading ONC total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+0.74%	—	+0.74%	—	$10,074
1Y	+29.60%	29.60%	+29.60%	—	$12,961
3Y	+23.39%	7.26%	+23.39%	—	$12,339
5Y	-0.22%	-0.04%	-0.22%	—	$9,978
10Y	+1094.05%	28.15%	+1094.05%	—	$119,405
15Y	+1006.36%	17.38%	+1006.36%	—	$110,636
20Y	+1006.36%	12.77%	+1006.36%	—	$110,636
30Y	+1006.35%	8.34%	+1006.35%	—	$110,635

Risk & Highlights

Best Year+214.72%2017

Worst Year-20.42%2023

Max Drawdown-27.22%2025-11-12 → 2026-03-23

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+1.92%	+1.92%	—	+0.41%	+1.5pp
2025	+65.11%	+65.11%	—	+16.64%	+48.5pp
2024	+4.36%	+4.36%	—	+24.00%	-19.6pp
2023	-20.42%	-20.42%	—	+24.81%	-45.2pp
2022	-18.41%	-18.41%	—	-19.95%	+1.5pp

ONC underperformed the S&P 500 by 1.72pp over the past year (+29.60% vs +31.32%).

Loading summary...

ONC Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
ONCBeOne Medicines Ltd.	$33.5B	+3.6%	+0.7%	+29.6%	—	+23.4%	-0.2%	+1094.1%
ZYMEZymeworks Inc.	$2.1B	+6.8%	+3.7%	+135.2%	—	+215.2%	-6.4%	+112.4%
RCUSArcus Biosciences, Inc.	$2.6B	+16.9%	+11.6%	+220.2%	—	+31.0%	-13.7%	+52.9%
TGTXTG Therapeutics, Inc.	$6.7B	+24.6%	+43.3%	+20.4%	—	+26.8%	+5.3%	+425.9%
KYMRKymera Therapeutics, Inc.	$7.0B	+1.2%	+18.6%	+201.9%	—	+211.0%	+110.5%	+159.4%
MGNXMacroGenics, Inc.	$191M	-5.3%	+87.0%	+104.8%	—	-58.4%	-90.6%	-83.4%
IMVTImmunovant, Inc.	$5.8B	+15.2%	+10.7%	+107.2%	—	+48.4%	+73.9%	+188.1%
HALOHalozyme Therapeutics, Inc.	$7.8B	+5.2%	-5.6%	+11.7%	—	+119.1%	+39.1%	+598.4%
ACADACADIA Pharmaceuticals Inc.	$3.7B	-3.8%	-17.9%	+47.7%	—	-0.3%	+2.5%	-22.3%
FOLDAmicus Therapeutics, Inc.	$4.5B	+0.3%	+1.5%	+134.1%	—	+19.0%	+50.9%	+125.0%
PTCTPTC Therapeutics, Inc.	$5.5B	-3.3%	-13.2%	+84.1%	—	+19.9%	+65.2%	+839.5%

Compare:ONC vs ZYME ONC vs RCUS ONC vs TGTX ONC vs ZYME vs RCUS

About ONC Dividend Returns

BeOne Medicines Ltd. (ONC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of ONC over the past year?

BeOne Medicines Ltd. (ONC) delivered a return of 29.60% over the past year. Since ONC does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in ONC be worth today?

A $10,000 investment in BeOne Medicines Ltd. one year ago would be worth $12,961 today, representing a gain of $2,961.

Q3Does ONC pay dividends?

BeOne Medicines Ltd. (ONC) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ONC, the total return equals the price-only return.

Q4Did ONC beat the S&P 500?

No, BeOne Medicines Ltd. (ONC) underperformed the S&P 500 by 1.72 percentage points over the past year. ONC delivered a total return of 29.60%, compared to the S&P 500's 31.32%. This means a passive S&P 500 index fund outperformed ONC by 1.72pp during this period.

Q5What is ONC's worst drawdown?

BeOne Medicines Ltd. (ONC) experienced a maximum drawdown of -27.22% over the past year, declining from its peak on 2025-11-12 to its trough on 2026-03-23. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is ONC's long-term total return over 10, 20, or 30 years?

Here are BeOne Medicines Ltd. (ONC)'s long-term returns with dividends reinvested. Over 10 years, the total return is 1094.1% (28.1% CAGR) — $10,000 would have grown to $119,405. Over 20 years: 1006.4% total return (12.8% CAGR) — $10,000 → $110,636. Over 30 years: 1006.4% total return (8.3% CAGR) — $10,000 → $110,635. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was ONC's best and worst year?

BeOne Medicines Ltd.'s best calendar year was 2017 with a total return of 214.7%. Its worst year was 2023 with a total return of -20.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 235.1 percentage points.